Skip to search formSkip to main contentSkip to account menu
Cannabinoid receptor localization in brain.
TLDR
The potencies of a series of natural and synthetic cannabinoids as competitors of [3H]CP 55,940 binding correlated closely with their relative potencies in several biological assays, suggesting that the receptor characterized in the in vitro assay is the same receptor that mediates behavioral and pharmacological effects of cannabinoids, including human subjective experience.
View on PubMed
Amphetamine‐type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin
TLDR
In vitro methods determined the neurochemical mechanism of action of amphetamine, 3,4‐methylenedioxymethamphetamine (MDMA), (+)‐methamphetamine, ephedrine, phentermine, and aminorex, and demonstrated that the most potent effect of these stimulants is to release NE.
View on Wiley
Stress-induced relapse to cocaine seeking: roles for the CRF2 receptor and CRF-binding protein in the ventral tegmental area of the rat
TLDR
A role of VTA CRF-BP is revealed and an involvement of CRF2R is suggested in the effectiveness of stress in triggering glutamate and dopamine release and cocaine seeking in drug-experienced animals.
View on Springer
Effects of Corticotropin-Releasing Factor on Neuronal Activity in the Serotonergic Dorsal Raphe Nucleus
View on Nature
Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist
TLDR
Salvinorin A is the first naturally occurring nonnitrogenous opioid-receptor subtype-selective agonist for κ opioid receptors and may represent novel psychotherapeutic compounds for diseases manifested by perceptual distortions (e.g., schizophrenia, dementia, and bipolar disorders).
View on Publisher
Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.
TLDR
Salvinorin A is the first naturally occurring nonnitrogenous opioid-receptor subtype-selective agonist for kappa opioid receptors, and may represent novel psychotherapeutic compounds for diseases manifested by perceptual distortions (e.g., schizophrenia, dementia, and bipolar disorders).
View on PubMed
In vivo Effects of Abused ‘Bath Salt’ Constituent 3,4-methylenedioxypyrovalerone (MDPV) in Mice: Drug Discrimination, Thermoregulation, and Locomotor Activity
TLDR
Although the interoceptive effects of MDPV are similar to those of MDMA and METH, direct effects on thermoregulatory processes and locomotor activity are likely mediated by different mechanisms than those of ecstasy.
View on Nature
The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia.
View on PubMed
Evidence that opioids may have toll-like receptor 4 and MD-2 effects
View on Elsevier
Sigma receptors: biology and function.
View on PubMed
...
...
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License